GASTROINTESTINAL STROMAL TUMOR (GIST)
Clinical trials for GASTROINTESTINAL STROMAL TUMOR (GIST) explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMOR (GIST) trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMOR (GIST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial offers hope for tough stomach tumors
Disease control OngoingThis study is testing whether adding a new drug called MEK162 to the standard treatment (imatinib) works better for people with advanced gastrointestinal stromal tumors (GIST). The research first finds the safest dose, then checks if the combination helps shrink tumors and delays…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists map DNA of rare cancer in search for new treatments
Knowledge-focused OngoingThis study aims to understand the genetic makeup of a rare stomach cancer (GIST) in Taiwanese patients who do not have the most common genetic mutations. Researchers will analyze tumor samples from 50 patients to create a genetic profile and see how it relates to their health out…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Feb 23, 2026 14:57 UTC